EWTX logo

Edgewise Therapeutics (EWTX) Current liabilities

annual current liabilities:

$23.86M+$7.09M(+42.27%)
December 31, 2024

Summary

  • As of today (July 6, 2025), EWTX annual total current liabilities is $23.86 million, with the most recent change of +$7.09 million (+42.27%) on December 31, 2024.
  • During the last 3 years, EWTX annual current liabilities has risen by +$13.34 million (+126.78%).
  • EWTX annual current liabilities is now at all-time high.

Performance

EWTX Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

quarterly current liabilities:

$21.11M-$2.75M(-11.50%)
March 31, 2025

Summary

  • As of today (July 6, 2025), EWTX quarterly total current liabilities is $21.11 million, with the most recent change of -$2.75 million (-11.50%) on March 31, 2025.
  • Over the past year, EWTX quarterly current liabilities has increased by +$6.51 million (+44.62%).
  • EWTX quarterly current liabilities is now -11.50% below its all-time high of $23.86 million, reached on December 31, 2024.

Performance

EWTX quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

EWTX Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+42.3%+44.6%
3 y3 years+126.8%+111.1%
5 y5 years+2007.8%-

EWTX Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+126.8%-11.5%+129.1%
5 y5-yearat high+2007.8%-11.5%+386.3%
alltimeall timeat high+2007.8%-11.5%+386.3%

EWTX Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$21.11M(-11.5%)
Dec 2024
$23.86M(+42.3%)
$23.86M(+25.9%)
Sep 2024
-
$18.96M(+10.4%)
Jun 2024
-
$17.18M(+17.6%)
Mar 2024
-
$14.60M(-12.9%)
Dec 2023
$16.77M(+1.1%)
$16.77M(+2.7%)
Sep 2023
-
$16.34M(+13.5%)
Jun 2023
-
$14.40M(+13.3%)
Mar 2023
-
$12.71M(-23.3%)
DateAnnualQuarterly
Dec 2022
$16.59M(+57.6%)
$16.59M(+24.7%)
Sep 2022
-
$13.30M(+44.3%)
Jun 2022
-
$9.22M(-7.9%)
Mar 2022
-
$10.00M(-4.9%)
Dec 2021
$10.52M(+142.3%)
$10.52M(+20.2%)
Sep 2021
-
$8.75M(+29.9%)
Jun 2021
-
$6.74M(+38.9%)
Mar 2021
-
$4.85M(+11.7%)
Dec 2020
$4.34M(+283.6%)
$4.34M
Dec 2019
$1.13M
-

FAQ

  • What is Edgewise Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Edgewise Therapeutics?
  • What is Edgewise Therapeutics annual current liabilities year-on-year change?
  • What is Edgewise Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Edgewise Therapeutics?
  • What is Edgewise Therapeutics quarterly current liabilities year-on-year change?

What is Edgewise Therapeutics annual total current liabilities?

The current annual current liabilities of EWTX is $23.86M

What is the all time high annual current liabilities for Edgewise Therapeutics?

Edgewise Therapeutics all-time high annual total current liabilities is $23.86M

What is Edgewise Therapeutics annual current liabilities year-on-year change?

Over the past year, EWTX annual total current liabilities has changed by +$7.09M (+42.27%)

What is Edgewise Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of EWTX is $21.11M

What is the all time high quarterly current liabilities for Edgewise Therapeutics?

Edgewise Therapeutics all-time high quarterly total current liabilities is $23.86M

What is Edgewise Therapeutics quarterly current liabilities year-on-year change?

Over the past year, EWTX quarterly total current liabilities has changed by +$6.51M (+44.62%)
On this page